Italy's Sara Errani, who was suspended by the International Tennis Federation (ITF) for two months after she failed a drug test, said she never took any banned substances.
"I never took, in my life and during my career, any prohibited substance," the 30-year-old Errani said in a statement posted in her Twitter account on Monday, reports Efe.
A urine sample that Errani provided on February 16 and was tested in Montreal contained letrozole, which is on the World Anti-Doping Agency's prohibited substances list, the ITF said in a statement.
"An Independent Tribunal ... has found that Sara Errani committed an Anti-Doping Rule Violation under Article 2.1 of the Programme and, as a consequence, has disqualified the affected results and imposed a period of ineligibility of two months, commencing on 3 August 2017," the ITF said.
Errani, for her part, said letrozole "is present in Femara, a medicine my mother has been using daily since 2012 for therapeutic purpose, further to a surgery for breast cancer, and therefore is present in the house where I am currently living."
The tennis player said she never took any letrozole and suspected that "accidental food contamination occurred at some stage in the house".
"I feel very frustrated. I had not done anything wrong," Errani said.
The ITF said Errani's results, points and prize money earned between February 16, when she provided the positive sample, and June 7, when she passed another drug test, would be disqualified.
Errani, the World No.98, made it to the semis at the Rabat International, her best singles result this season.
The Italian WTA Tour veteran reached her only Grand Slam final at the 2012 French Open.
--IANS
gau/vt
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
